Abundant IFN-gamma production by local T cells in respiratory syncytial virus-induced eosinophilic lung disease
- PMID: 9680139
- DOI: 10.1099/0022-1317-79-7-1751
Abundant IFN-gamma production by local T cells in respiratory syncytial virus-induced eosinophilic lung disease
Abstract
Respiratory syncytial virus (RSV) is a frequent cause of severe lung disease in young children. Primed T cells are required for virus clearance, but are causally implicated in the enhanced pathology seen following RSV infection of some infants and experimental animals vaccinated against the virus. In BALB/c mice, vaccination with recombinant vaccinia virus expressing the viral attachment protein (G) leads to pulmonary eosinophilia during subsequent infection, which indirect evidence suggests may be due to CD4+ Th2 cells. The production of IFN-gamma, IL-2, -4, -5 and -10 cytokine mRNA by RT-PCR and intracellular cytokines by flow cytometry following RSV challenge of vaccinated mice were therefore compared. Lung eosinophilia was associated with enhanced local recruitment of CD4+ cells in G sensitized mice, while CD8+ cells dominated in mice vaccinated with the viral fusion protein (F) or second matrix protein (M2). Lung eosinophilia was also associated with a localized reduction in IFN-gamma and increased IL-4 and IL-5 mRNA transcription as well as elevated RSV specific IgG1 antibody production. Th2 cytokine protein production by T cells showed no apparent change. Although IFN-gamma production diminished in eosinophilic mice, it remained the major cytokine found in lung T cells. It was concluded that lung eosinophilia can develop despite abundant IFN-gamma production by local T cells, but is associated with a shift in the balance between Th2 and Th1 cytokine production.
Similar articles
-
Priming with a secreted form of the fusion protein of respiratory syncytial virus (RSV) promotes interleukin-4 (IL-4) and IL-5 production but not pulmonary eosinophilia following RSV challenge.J Virol. 1999 Dec;73(12):10086-94. doi: 10.1128/JVI.73.12.10086-10094.1999. J Virol. 1999. PMID: 10559323 Free PMC article.
-
Virus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection.J Exp Med. 1997 Aug 4;186(3):421-32. doi: 10.1084/jem.186.3.421. J Exp Med. 1997. PMID: 9236194 Free PMC article.
-
Subcellular site of expression and route of vaccination influence pulmonary eosinophilia following respiratory syncytial virus challenge in BALB/c mice sensitized to the attachment G protein.J Immunol. 1998 Sep 1;161(5):2473-80. J Immunol. 1998. PMID: 9725246
-
The effect of IL-12 treatment on vaccine-enhanced illness during infection with respiratory syncytial virus.Dev Biol Stand. 1998;92:179-85. Dev Biol Stand. 1998. PMID: 9554273 Review.
-
Understanding respiratory syncytial virus (RSV) vaccine-enhanced disease.Immunol Res. 2007;39(1-3):225-39. doi: 10.1007/s12026-007-0071-6. Immunol Res. 2007. PMID: 17917067 Review.
Cited by
-
Modulation of protective immunity, eosinophilia, and cytokine responses by selective mutagenesis of a recombinant G protein vaccine against respiratory syncytial virus.J Virol. 2005 Apr;79(7):4527-32. doi: 10.1128/JVI.79.7.4527-4532.2005. J Virol. 2005. PMID: 15767454 Free PMC article.
-
Brief History and Characterization of Enhanced Respiratory Syncytial Virus Disease.Clin Vaccine Immunol. 2015 Dec 16;23(3):189-95. doi: 10.1128/CVI.00609-15. Clin Vaccine Immunol. 2015. PMID: 26677198 Free PMC article. Review.
-
Ovalbumin sensitization changes the inflammatory response to subsequent parainfluenza infection. Eosinophils mediate airway hyperresponsiveness, m(2) muscarinic receptor dysfunction, and antiviral effects.J Exp Med. 1999 Nov 15;190(10):1465-78. doi: 10.1084/jem.190.10.1465. J Exp Med. 1999. PMID: 10562321 Free PMC article.
-
Immunomodulation with IL-4R alpha antisense oligonucleotide prevents respiratory syncytial virus-mediated pulmonary disease.J Immunol. 2010 Oct 15;185(8):4804-11. doi: 10.4049/jimmunol.1000484. Epub 2010 Sep 22. J Immunol. 2010. PMID: 20861354 Free PMC article.
-
Virally expressed interleukin-10 ameliorates acute encephalomyelitis and chronic demyelination in coronavirus-infected mice.J Virol. 2011 Jul;85(14):6822-31. doi: 10.1128/JVI.00510-11. Epub 2011 May 18. J Virol. 2011. PMID: 21593179 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials